NCT06426706 TPVB or SPSIPB in Pain Management After VATS
| NCT ID | NCT06426706 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Koç University |
| Condition | Video-assisted Thoracoscopic Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2025-01-03 |
| Primary Completion | 2025-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2025-01-03 with a primary completion date of 2025-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the analgesic efficacy of thoracal paravertebral block (TPVB) and serratus posterior superior intercostal plane block (SPSIPB) in patients undergoing video-assisted thoracoscopic surgery (VATS). The main questions it aims to answer are: How will the total perioperative opioid consumption of the patients receiving two different blocks change? How will TPVB and SPSIPB effect the patients' numeric rating scores for pain in the postoperative 24-hour period? How will TPVB and SPSIPB effect the incidence of opioid related side effects? Participants will be divided in two groups: TPVB group will receive a TPVB before the surgery. SPSIPB group will receive a SPSIPB nerve block before the surgery. Researchers will compare the results between the groups to see the postoperative effects concerning opioid consumption as well as the pain scores, respiratory parameters and opioid associated side effects. The hypothesis of this study is that participants receiving SPSIPB for VATS will have a less total opioid consumption 24 hours postoperatively.
Eligibility Criteria
Inclusion Criteria: * Patients between the age of 18-80 undergoing video-assisted thoracoscopic surgery Exclusion Criteria: * Allergy to local anaesthetics Chronic opioid use history Patients with psychiatric disorders Patients who are not open to communication Patients with chronic organ failure Patients that do not give consent Patients that need emergency surgery within the first 24 hours of the initial surgery
Contact & Investigator
Kamil Darçın, MD
PRINCIPAL INVESTIGATOR
Koç University
Frequently Asked Questions
Who can join the NCT06426706 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Video-assisted Thoracoscopic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06426706 currently recruiting?
Yes, NCT06426706 is actively recruiting participants. Contact the research team at drdarcink@gmail.com for enrollment information.
Where is the NCT06426706 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06426706 clinical trial?
NCT06426706 is sponsored by Koç University. The principal investigator is Kamil Darçın, MD at Koç University. The trial plans to enroll 44 participants.